Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1992 4
1993 5
1994 2
1995 1
1996 6
1997 7
1998 1
1999 1
2000 6
2001 4
2002 3
2003 2
2004 3
2005 2
2006 3
2007 4
2008 4
2009 6
2010 7
2011 5
2012 3
2013 3
2014 2
2015 4
2016 3
2017 3
2018 5
2019 4
2020 8
2021 9
2022 12
2023 7
2024 6
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study.
Atia O, Shavit-Brunschwig Z, Mould DR, Stein R, Matar M, Aloi M, Ledder O, Focht G, Urlep D, Hyams J, Broide E, Weiss B, Levine J, Russell RK, Turner D. Atia O, et al. Among authors: broide e. Lancet Gastroenterol Hepatol. 2023 Jan;8(1):31-42. doi: 10.1016/S2468-1253(22)00307-7. Epub 2022 Oct 26. Lancet Gastroenterol Hepatol. 2023. PMID: 36306803
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial.
Ratziu V, de Guevara L, Safadi R, Poordad F, Fuster F, Flores-Figueroa J, Arrese M, Fracanzani AL, Ben Bashat D, Lackner K, Gorfine T, Kadosh S, Oren R, Halperin M, Hayardeny L, Loomba R, Friedman S; ARREST investigator study group; Sanyal AJ. Ratziu V, et al. Nat Med. 2021 Oct;27(10):1825-1835. doi: 10.1038/s41591-021-01495-3. Epub 2021 Oct 7. Nat Med. 2021. PMID: 34621052 Free PMC article. Clinical Trial.
Treatment of oral immunotherapy-associated eosinophilic esophagitis.
Epstein-Rigbi N, Elizur A, Levy MB, Nachshon L, Koren Y, Shalem Z, Broide E, Goldberg MR. Epstein-Rigbi N, et al. Among authors: broide e. J Allergy Clin Immunol Pract. 2023 Apr;11(4):1303-1305.e2. doi: 10.1016/j.jaip.2022.11.010. Epub 2022 Nov 21. J Allergy Clin Immunol Pract. 2023. PMID: 36423867 No abstract available.
Whole Food Diet Induces Remission in Children and Young Adults With Mild to Moderate Crohn's Disease and Is More Tolerable Than Exclusive Enteral Nutrition: A Randomized Controlled Trial.
Frutkoff YA, Plotkin L, Pollak D, Livovsky J, Focht G, Lev-Tzion R, Ledder O, Assa A, Yogev D, Orlanski-Meyer E, Broide E, Kierkuś J, Kang B, Weiss B, Aloi M, Schwerd T, Shouval DS, Bramuzzo M, Griffiths AM, Yassour M, Turner D. Frutkoff YA, et al. Among authors: broide e. Gastroenterology. 2025 Jun 17:S0016-5085(25)00896-0. doi: 10.1053/j.gastro.2025.06.011. Online ahead of print. Gastroenterology. 2025. PMID: 40553742 Free article.
Upadacitinib Maintenance Therapy in Crohn's Disease: Final Results From the Randomized Phase 3 U-ENDURE Study.
Panaccione R, Regueiro M, Lee SD, Atreya R, Pedersen G, Broide E, Rodriguez C, van Bodegraven AA, Dubcenco E, Lacerda AP, Feng T, Geng Z, Wang T, van Haaren S, Anyanwu SI, Panés J. Panaccione R, et al. Among authors: broide e. Clin Gastroenterol Hepatol. 2025 Jul 28:S1542-3565(25)00643-3. doi: 10.1016/j.cgh.2025.07.028. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 40738276 Free article.
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study.
Atia O, Shavit-Brunschwig Z, Lev-Tzion R, Stein R, Broide E, Urlep D, Hyams J, Weiss B, Aloi M, Assa A, Gerasimidis K, Nichols B, Russell RK, Turner D. Atia O, et al. Among authors: broide e. Lancet Gastroenterol Hepatol. 2025 Mar;10(3):234-247. doi: 10.1016/S2468-1253(24)00319-4. Epub 2025 Jan 6. Lancet Gastroenterol Hepatol. 2025. PMID: 39788134
Caustic Ingestion in Children: The Otolaryngologist Perspective.
Shcherbaeva T, Muallem Kalmovich L, Shalem T, Broide E, Gavriel H, Pitaro J. Shcherbaeva T, et al. Among authors: broide e. Pediatr Emerg Care. 2022 Sep 1;38(9):e1541-e1544. doi: 10.1097/PEC.0000000000002738. Epub 2022 May 17. Pediatr Emerg Care. 2022. PMID: 35580175
140 results